Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

13 novembre 2018

10:15
NYU Winthrop Hospital announced that it has developed a novel diagnostic method for evaluating a common swallowing and feeding dysfunction that impacts 30?70% of very-low-birth-weight preterm infants. The condition, dysphagia, can result in serious...

10:07
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced the presentation of pre-clinical evidence for UB-312, a Parkinson's disease vaccine candidate, at the...

10:00
Ora® Inc. has been retained by ProQR Therapeutics to provide standardized mobility test services for ProQR's Phase 3 development program for Leber's Congenital Amaurosis Type 10. On September 5th 2018, ProQR Therapeutics announced positive interim...

09:24
Nestlé Health Science today announced the publication of positive results from the OPTIWIN study in Obesity,1 the official peer-reviewed journal of The Obesity Society. OPTIWIN, which represents the largest year-long, randomized, clinical trial of a...

09:00
DNAtrix and Valo Therapeutics today announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.  DNAtrix's clinical stage oncolytic adenovirus...

09:00
The 2nd AI-PI: Drug Discovery 2019 Summit returns to San Francisco, February 27 - 28, 2019. Key decision makers from pharma, biotech drug developers and technology companies will meet not to only discuss but share real world technical insight and...

08:48
Oramed Pharmaceuticals Inc.  (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has successfully randomized more than 50% of the expected 285 patients for its...

08:30
Arena Pharmaceuticals, Inc.  presented preclinical data for its recently announced investigational compound, APD418, a first-in-class calcium-independent myofilament derepressor (CMD), ß3 adrenergic receptor (AdrR) selective antagonist, at...

08:00
Bio2 Technologies, Inc., a privately held orthopedics company, announced today that it received U.S. Food and Drug Administration ("FDA") approval to begin enrollment in an IDE clinical study to evaluate Vitrium as a cervical interbody fusion...

08:00
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, today announced that the first patient has been dosed in the Company's Phase 2 clinical program to evaluate the efficacy and safety of APX001 in the...

08:00
OncoSec Medical Inc., (OncoSec) , a company developing intratumoral cancer immunotherapies, today announced that TAVOtm will be featured in two poster sessions during the 2018 San Antonio Breast Cancer Symposium (SABCS) taking place December 4-8 in...

07:30
Aridis Pharmaceuticals, Inc. , a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections, today announces financial results,...

07:15
Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma" or the "Company"), a globally-focused company in research and development of innovative drugs, announced today that the company presented the new clinical data of the dual Bcl-2/Bcl-xL...

07:00
Sierra Oncology, Inc. , a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs in hematology and oncology, today reported preclinical data for its novel oral...

07:00
Sutro Biopharma, Inc. , today announced that the U.S. Food and Drug Administration (FDA) has concluded their 30-day review of the Investigational New Drug (IND) application for STRO-002 to be evaluated in a Phase 1 clinical study as a potential...

07:00
Compugen Ltd. , a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that a patent for COM902, the Company's TIGIT therapeutic antibody candidate, has been issued by the United States Patent and...

06:00
The Canadian Partnership Against Cancer (the Partnership) has released their 2018 Cancer System Performance Report. This is the latest in a series of reports that shine a light on areas of Canada's cancer system ? from prevention and screening,...

06:00
Le Partenariat canadien contre le cancer (le Partenariat) a publié son Rapport de 2018 sur le rendement du système de lutte contre le cancer. Il s'agit du dernier d'une série de rapports qui mettent en lumière les secteurs du système canadien de...

05:20
The global liquid handling technology market is expected to reach USD 5.54 billion by 2025, according to a new report by Grand View Research, Inc. Major pharmaceutical and biopharmaceutical companies are rapidly integrating robotic solutions...

04:00
Findings support development of ?? T cells for gastrointestinal diseases  GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies for cancer and other diseases announced today the publication in Nature...

03:00
GenomOncology, LLC (GO) announced today that it was selected by the Indiana University School of Medicine to utilize GO's proprietary match algorithm and GO's extensive Knowledge Management System (KMS) application programming interface (API) suite...


12 novembre 2018

19:00
Innovent Biologics, Inc. (Innovent) (HKEX: 1801), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announced today that National Medical Products Administration (NMPA, successor to CFDA) has...

18:55
Viking Therapeutics, Inc. (Viking) , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the presentation of results from the company's 12-week Phase 2 study...

16:30
Angion Biomedica and Sinovant Sciences today announced a collaboration and license agreement for BB3, Angion's investigational small molecule mimetic of hepatocyte growth factor (HGF), in the People's Republic of China, Hong Kong, Macau, and Taiwan...

16:00
Amgen today announced the final report of the Open-Label Study of Long-TERm Evaluation Against LDL-C (OSLER-1), demonstrating long-term treatment with Repatha® (evolocumab) was associated with robust and consistent reductions in low-density...

15:45
There are less than 12 weeks until the 15th Annual WORLDSymposium 2019 Research Congress dedicated to lysosomal diseases. The annual research meeting, taking place 4th ? 8th February 2019 in Orlando, Florida, is now accepting late-breaking abstract...

14:51
Pharmazz, Inc., today announced that data from the Phase 2 clinical study in patients with hypovolemic shock, were presented in the Drug Discovery-Heart Failure Oral Abstracts Session II at the American Heart Association Scientific Sessions in...

14:48
Northern Green Canada Inc. (NGC) commissioned Cannabis Research Associates (CRA), in co-operation with their R&D subsidiary company Northern Green Sciences (NGS) to conduct a multi-phase study Cannabis For Opioid Substitution Trial (COST) approved by...

13:09
Feinstein Institute for Medical Research Professor David Eidelberg, MD, won the fourth annual Bachmann-Strauss Prize for Excellence in Dystonia Research. Dr. Eidelberg received an unrestricted $100,000 grant for his use of innovative brain imaging...

13:03
Two Abstracts Featuring Perspectum Diagnostics' MRCP+ Accepted for Presentation at The Liver Meeting® 2018  The clinical utility of quantitative metrics produced by MRCP+ for discriminating biliary disease was the focus of several abstracts accepted...

12:00
Royal Philips , a global leader in health technology, today announced enrollment of the first U.S. patient in the Stellarex ILLUMENATE Below-the-Knee (BTK) Investigational Device Exemption (IDE) study, led by principal investigators Dr. Bill Gray and...

11:55
The disruptive innovation for autonomous management of T1D   Diabeloop announced today it has received the CE marking for the DBLG1tm, its innovative technological solution to radically improve quality of life for T1D patients through better blood...

11:48
Intervention chirurgicale effectuée au NYU Langone Orthopedic Hospital à New York par un chirurgien de la médecine du sport, Eric Strauss, MD    CartiHeal, le développeur d'Agili-C, un implant exclusif destiné au traitement des lésions de la...

11:00
An experimental drug may be effective against a deadly form of pancreatic cancer when used in combination with other immune-boosting therapies, according to a cover study publishing online Nov. 12 in Cancer Cell. The findings revolve around the...

10:58
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced David Eidelberg, MD, professor and head of the Feinstein Institute for Medical Research's Center for Neurosciences and professor of Molecular Medicine and Neurology at the Donald...

10:46
PolyPid Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, locally administered therapies for post-surgical complications, announced today that the United States Food and Drug Administration (FDA) has...

09:30
Monteris Medical, a pioneer and leader in the emerging market for minimally invasive, image-guided laser ablation systems, announced that the favorable results of its LAASR (Laser Ablation After Stereotactic Radiosurgery) clinical study have been...

09:00
Israeli biotechnology company Kadimastem announces the approval by the European Union and the Israel Innovation Authority, to receive a joint research grant under the Eurostars program, for the clinical development of the company's technology for...

09:00
Nyxoah S.A., a medical device company focused on the development and commercialization of a best-in-class hypoglossal nerve stimulation (HGNS) therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it successfully raised an...

08:30
Theravance Biopharma, Inc. ("Theravance Biopharma") today highlighted that the European Commission authorized an expanded label for once-daily Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol 'FF/UMEC/VI'), recognizing the product's...

08:01
Surgery performed at NYU Langone Orthopedic Hospital in New York by sports medicine surgeon Eric Strauss, MD CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, announced today the successful...

08:00
NeoLight, an empathy-driven medical device company that designs, engineers, and manufactures technologies to treat infants with life-threatening medical conditions, announces today interim data from an ongoing clinical study on the efficacy of...

08:00
NGM Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on harnessing powerful biology to develop transformative therapeutics for patients, today announced preliminary results from a Phase 1b proof-of-concept clinical trial of...

07:30
Tris Pharma, Inc. (Tris), a biopharmaceutical company focused on developing innovative products that deliver meaningful patient benefits, today announced that it presented four scientific posters on DYANAVEL XR at the 2018 NEI Congress in Orlando,...

07:08
SERAXIS Inc., a rapidly growing regenerative medicine company today announced the publication of important trial considerations for SR-01, its pluripotent stem cell-derived islet therapy for insulin-dependent diabetes. An...

07:08
Stéphane Le Roy has been appointed President Business Area Surgical Workflows and member of the Getinge Executive Team. Stéphane most recently held the position of Regional President of South West Europe, in Getinge. In his new role, Stéphane will be...

07:00
Leading researchers from the U.S., U.K., and Europe at a Swiss conference last month reported progress on incriminating several infectious agents as possible triggers of Alzheimer's disease, says Leslie Norins, MD, PhD, a speaker and CEO of...

06:00
Nyxoah S.A., a medical device company focused on the development and commercialization of a best-in-class hypoglossal nerve stimulation (HGNS) therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it successfully raised an...

03:00
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that BBT-401, the first anti-Pellino-1 compound currently under development for ulcerative colitis (UC) treatment, proved its safety and...


11 novembre 2018

11:45
Novartis announced today results of the landmark PIONEER-HF trial showing that in-hospital initiation of Entresto tablets provided superior benefit compared to enalapril?a heart failure medication commonly used?in patients with HFrEF who had been...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17